Page last updated: 2024-08-24

adenosine and Thrombosis

adenosine has been researched along with Thrombosis in 120 studies

Research

Studies (120)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (8.33)	18.7374
1990's	11 (9.17)	18.2507
2000's	12 (10.00)	29.6817
2010's	81 (67.50)	24.3611
2020's	6 (5.00)	2.80

Authors

Authors	Studies
Han, K; Huang, X; Ma, M; Sun, T; Yang, S; Zhao, Z; Zhou, Y	1
Cheung, SS; Hellsten, Y; Lundberg Slingsby, MH; Nørregaard, LB; Wickham, KA	1
Cheng, XD; Li, YJ; Wang, JH; Wang, L; Yang, B; Yang, X; Yu, NW; Zhang, J; Zhang, Q; Zhang, X	1
Arthur, JM; Arulprakash, N; Corken, A; Dai, J; Davis, O; Hedayati, SS; Jain, N; Mehta, JL; Phadnis, MA; Rahmatallah, Y; Smyth, S; Ware, J	1
Rozalski, M; Wolska, N	1
Altun, S; Çetinbaş, A; Okur, Mİ; Özercan, İ; Öztan, M; Yıldız Altun, A	1
Altié, A; Brouilly, N; Carminita, E; Crescence, L; Dubois, C; Panicot-Dubois, L	1
Cui, JG; Huang, XH; Liu, G; Lu, J; Wu, X; Zhao, XY; Zheng, XX	1
Budaj, A; Ramotowski, B; Żuk, A	1
Anuwatworn, A; Kumar, V; Petrasko, M; Stys, A; Yee, J	1
Dobesh, PP; Patel, M	1
Cao, PG; Guo, DD; Quan, AJ; Shang, LL; Zhao, HY	1
Björkman, JA; Forsberg, GB; Hansson, GI; Nylander, S; von Bahr, H; Warner, TD; Zachrisson, H	1
Asseburg, C; Giannitsis, E; Katus, H; Theidel, U	1
Bode, C; Boeynaems, JM; Duerschmied, D; Guenther, F; Hein, L; Herr, N; Idzko, M; Mauler, M; Robaye, B; Roming, F; Von Zur Muhlen, C; Witsch, T	1
Becker, RC; Cannon, CP; Harrington, RA; James, SK; Pieper, KS; Steg, PG; Storey, RF; Wallentin, L	2
Abtahian, F; Hu, S; Jang, IK; Jia, H; Kato, K; McNulty, I; Tian, J; Vergallo, R; Yonetsu, T	1
Biondi-Zoccai, G; Dinicolantonio, JJ	1
Cameron, AM; Cengiz-Seval, G; Girotra, M; Gulsen, MT; Gurakar, A; Price, J; Segev, DL; Singh, VK	1
DiNicolantonio, JJ; Serebruany, VL	1
Ackman, ML; Bauer, RD; Bell, AD; Cartier, R; Chan, WS; Douketis, J; Mehta, SR; Roussin, A; Schnell, G; Tanguay, JF; Verma, S; Wong, G	1
Casassus, F; Fiore, M; Horovitz, A; Leroux, L; Pons, AC	1
Hartmark-Hill, JR; Tsang, K	1
Bäckstrom, J; Bhal, V; Caughran, AT; Enerbäck, M; Houng, AK; Houser, KH; Jennings, LK; Lands, LT; Reed, GL; Speich, HE	1
Angiolillo, DJ; Capodanno, D	1
Bouatou, Y; Gabrielli, A; Saudan, P	1
Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E	1
Alessi, MC; Bassez, C; Bonnet, G; Bonnet, JL; Cuisset, T; Deharo, P; Lambert, M; Morange, P; Pankert, M; Quilici, J; Verdier, V	1
Ge, J; Qian, J; Wang, Q; Wu, H; Zhou, J	1
Dobesh, PP; Oestreich, JH	1
Bacchini, S; Bongo, AS; Brunelleschi, S; Cavallino, C; Lupi, A; Rametta, F; Rognoni, A; Rosso, R; Secco, GG; Veia, A	1
Eichinger, S; Gouya, G; Kapiotis, S; Kyrle, PA; Litschauer, B; Mayer, P; Smerda, L; Weisshaar, S; Wolzt, M	1
Alarcón, M; Caballero, J; Fuentes, E; Mezzano, D; Palomo, I; Pereira, J	1
Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H	1
Cho, JH; Ihm, CG; Jeong, KH; Kim, JB; Kim, KS; Kim, W; Kim, WS; Lee, TW; Woo, JS	1
Dhillon, S	1
Keaney, JF	1
Kanorskiĭ, SG	1
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Sartori, C; Schaffer, A; Suryapranata, H; Verdoia, M	1
Cho, YR; Guo, LZ; Jin, CD; Kim, MH; Kim, YD; Lee, YS; Park, JS; Park, K; Park, TH	1
Fuentes, E; Palomo, I	1
Al-Kindi, SG; Benatti, RD; Deo, S; ElAmm, C; Ginwalla, M; Medalion, B; Oliveira, GH; Osman, MN; Park, SJ; Qattan, MY; Simon, DI	1
Chua, T; Gruntowicz, D; Johnson, SG; Morlock, RJ	1
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M	1
Ajjan, RA; Dockrell, DH; Ecob, R; Faulkner, RE; Judge, HM; Khan, H; Outteridge, SN; Phoenix, F; Sabroe, I; Sangha, GK; Storey, RF; Thomas, MR; West, LE	1
Giusti, B; Grifoni, E; Marcucci, R	1
Millar, CG; Noman, A; Parasuraman, SK; Teo, AI	1
Abacı, A; Aygencel, G; Kara, İ; Okuyan, H; Türkoğlu, M; Yıldırım, F	1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD	1
Abu-Much, A; Asher, E; Atar, S; Beigel, R; Goldenberg, I; Matetzky, S; Mazin, I; Polak, A; Sabbag, A; Segev, A; Shlezinger, M; Zahger, D	1
Cattaneo, M; Cipriani, M; Femia, EA; Frigerio, M; Morici, N; Oliva, F; Perna, E	1
Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG	1
Cattabiani, MA; Di Vito, L; Gatto, L; Limbruno, U; Marco, V; Micari, A; Pawlowski, T; Prati, F; Romagnoli, E; Trivisonno, A; Versaci, F	1
Heath, RS; Hugentobler, KG; Rasparini, M; Sharif, H; Turner, NJ	1
Barbieri, L; Brouwer, MA; Camaro, C; Damen, SA; de Boer, MJ; De Luca, G; Kedhi, E; Lee, SW; Ligtenberg, E; Rognoni, A; Suryapranata, H; van T Hof, AW; Verdoia, M	1
Barillà, F; Borzi, M; Camici, P; Cas, LD; Di Biase, M; Filardi, PP; Indolfi, C; Mercuro, G; Montemurro, V; Padeletti, L; Pelliccia, F; Romeo, F; Vizza, CD	1
Gurbel, PA; Kubica, J; Myat, A; Tantry, US	1
Brice, AE; Haynick, M; Hernandez, GA; Mendoza, CE; Sanchez, M	1
Akhmedov, A; Beer, JH; Bonetti, NR; Camici, GG; Gaul, DS; Glanzmann, M; Keller, S; Lüscher, TF; Matter, CM; Reiner, MF; Ruf, W; Savarese, G; Stivala, S; Yang, Z; Zhu, C	1
Adeola, O; Chen, R; Fay, WP; Jeong, SS; Ji, Y; Strawn, TL	1
Ariotti, S; Gargiulo, G; Valgimigli, M	1
Chan, R; Kong, SL; Kwok, J; Lee, S; Shea, C; Siu, D; Tam, CC; Tang, WH; Wong, A; Yung, A	1
Bonan, CD; Morsch, VM; Schetinger, MR; Wyse, AT	1
Dai, J; Houard, X; Louedec, L; Michel, JB; Philippe, M	1
Doggrell, SA	1
Berntsson, P; Björkman, JA; van Giezen, JJ; Zachrisson, H	1
Angiolillo, DJ; Capodanno, D; Dharmashankar, K	1
Kosior, D; Marczewski, MM; Postula, M	1
Gurbel, PA; Kereiakes, DJ; Tantry, US	1
Francis, SE; Jackman, LE; Judge, HM; Nylander, S; Patil, SB; Storey, RF	1
Cayla, G; Collet, JP; Montalescot, G	1
Gaglia, MA; Waksman, R	1
Hamad, B; Huber, K; Kirkpatrick, P	1
Storey, RF	1
Chauhan, A; More, RS; Morgan, KP	1
Ding, Z; Du, H; Fan, Z; Gross, PL; Hu, L; Kunapuli, SP; Ni, R; Wei, X; Ye, J; Yin, K; Zhang, S; Zhang, X; Zhang, Y	1
De Mey, JG; Feijge, MA; Heemskerk, JW; Kuijpers, MJ; Megens, RT; Nikookhesal, E; oude Egbrink, MG; van Giezen, JJ	1
Campbell, JA; Davis, EM; Knezevich, JT; Packard, KA	1
Johnston-Cox, HA; Koupenova, M; Ravid, K	1
Coulden, RA; Grundy, BJ; Khoo, JP; McCann, GP; Sonnex, EP; Steadman, CD	1
Hausleiter, J; Joner, M; Kastrati, A; Massberg, S; Okrojek, R; Orban, M; Riegger, J; Sibbing, D; Tada, T	1
Freynhofer, MK; Höchtl, T; Huber, K; Mahla, E; Prüller, F	1
Barn, K; Steinhubl, SR	1
Giannitsis, E; Katus, HA	1
Ding, Z; Du, H; Liu, G; Pan, C; Wei, X; Ye, J; Zhang, S; Zhang, Y	1
Becker, RC; Cornel, JH; Goodman, SG; Harrington, R; Horrow, J; Husted, S; James, S; Katus, H; Santoso, A; Steg, G; Storey, RF; Sun, JL; Vintila, M; Wallentin, L	1
Dechant, LM	1
Chatterjee, S; Frankel, R; Ghose, A; Guha, G; Mukherjee, D; Sharma, A	1
Angiolillo, DJ; Ardissino, D; Cannon, CP; Horrow, J; Husted, S; James, SK; Kohli, P; Maurer, G; Morais, J; Nicolau, JC; Oto, A; Reyes, E; Storey, RF; Wallentin, L	1
Hashimoto, M; Jakubowski, J; Ogawa, T; Ohno, K; Sugidachi, A; Tomizawa, A	1
BORN, GV; HONOUR, AJ; MITCHELL, JR	1
PHILP, RB; WRIGHT, HP	1
Campbell, DJ; Cowan, PJ; d'Apice, AJ; Dwyer, KM; Fisicaro, N; Gock, H; Kaczmarek, E; Murray-Segal, LJ; Mysore, TB; Nandurkar, HH; Robson, SC	1
Heldman, AW; St John, M	1
Humphries, RG; van Giezen, JJ	1
Chen, JP	1
Bailey, A; Barton, P; Birkinshaw, TN; Bonnert, RV; Brown, RC; Chapman, D; Dixon, J; Guile, SD; Humphries, RG; Hunt, SF; Ince, F; Ingall, AH; Kirk, IP; Leeson, PD; Leff, P; Lewis, RJ; Martin, BP; McGinnity, DF; Mortimore, MP; Paine, SW; Pairaudeau, G; Patel, A; Rigby, AJ; Riley, RJ; Springthorpe, B; Teobald, BJ; Tomlinson, W; Webborn, PJ; Willis, PA	1
Angiolillo, DJ	1
Ikeda, Y; Nagano, M; Nakashima, M; Takiguchi, Y	1
Fisher, RA; Madden, R; Munda, R	1
Benoit, G; Bensadoun, H; Blanchet, P; Charpentier, B; Douguet, D; Jaber, N; Jardin, A; Moukarzel, M	1
Abecassis, MM; Douzdjian, V; Sharp, WJ	1
Chiodini, S; Emre, S; Hytiroglou, P; Kishikawa, K; Menesses, P; Miller, CM; Mor, E; Schwartz, ME; Sheiner, PA	1
Blumenstock, I; Büsing, M; Heimburger, N; Hopt, UT; Nader, A; Pfeffer, F; Schareck, W	1
Abe, M; Babazono, T; Hoshino, T; Ishida, H; Koike, T; Nakamura, M; Sato, S; Shinkai, M; Teraoka, S; Tomonaga, O	1
De Ville de Goyet, J; Gigi, J; Lerut, J; Martínez, JA; Otte, JB; Rahier, J; Reding, R; Rigamonti, W	1
Nguyen, A	1
Berndt, MC; Bobik, A; Jennings, G; Ramsay, D; Taylor, AJ	1
Lewis, GP; Lieberman, GE; Peters, TJ	1
Yasunaga, K	1
Altomonte, F; Armani, U; Griffanti-Bartoli, F; Piana, A	1
Born, GV; Galletti, PM; Richardson, PD	1
Langnas, AN; Li, S; Marujo, W; Shaw, BW; Stratta, RJ; Wood, RP	1
Baumann, FG; Crooke, G; Halff, GA; Harris, L; Teperman, LW; Weil, R	1
Belzer, FO; D'Alessandro, AM; Kalayoglu, M; Pirsch, JD; Sollinger, HW; Southard, JH	1
Barbenel, JC; Forbes, CD; Lowe, GD; Madhok, R; Saniabadi, AR; Shaw, B; Spowart, K	1
Banks, DC; Mitchell, JR	1
Weiss, HJ	1
Gowdey, CW; Philp, RB; Schacham, P	1

Reviews

31 review(s) available for adenosine and Thrombosis

Article	Year
Purinergic signaling: a potential therapeutic target for ischemic stroke. Purinergic signalling, 2023, Volume: 19, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Antigens, CD; Apyrase; Humans; Ischemic Stroke; Signal Transduction; Thrombosis	2023
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy. International journal of molecular sciences, 2019, Nov-03, Volume: 20, Issue:21 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Platelets; Cyclic AMP; Humans; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Thrombosis	2019
A Primer on Bleeding Risk and Management Strategies of Newer Oral Anti Platelet Agents in Cardiovascular Disease. South Dakota medicine : the journal of the South Dakota State Medical Association, 2016, Volume: 69, Issue:10 Topics: Adenosine; Administration, Oral; Aspirin; Cardiovascular Diseases; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine	2016
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease. Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:4 Topics: Adenosine; Atherosclerosis; Cardiovascular Diseases; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor	2017
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. The Canadian journal of cardiology, 2013, Volume: 29, Issue:11 Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Contraindications; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Secondary Prevention; Stents; Stroke; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2013
Ticagrelor (Brilinta) for secondary prevention of thrombotic events following acute coronary syndrome. American family physician, 2013, Dec-15, Volume: 88, Issue:12 Topics: Acute Coronary Syndrome; Adenosine; Drug Administration Schedule; Drug Costs; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; United States	2013
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions. Circulation. Cardiovascular interventions, 2014, Volume: 7, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Ticagrelor	2014
[Use of antiplatelet agents in patients with chronic kidney disease: what is the evidence?]. Revue medicale suisse, 2014, Feb-26, Volume: 10, Issue:419 Topics: Adenosine; Blood Platelet Disorders; Clopidogrel; Evidence-Based Practice; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Renal Insufficiency, Chronic; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2014
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease. Annals of medicine, 2014, Volume: 46, Issue:7 Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Meta-Analysis as Topic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Primary Prevention; Review Literature as Topic; Secondary Prevention; Stroke; Tetrazoles; Thrombosis; Ticagrelor; Ticlopidine	2014
Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy, 2014, Volume: 34, Issue:10 Topics: Acute Coronary Syndrome; Adenosine; Animals; Clinical Trials as Topic; Humans; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Treatment Outcome	2014
Ticagrelor: a novel drug for an old problem. Recent patents on cardiovascular drug discovery, 2014, Volume: 9, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Animals; Blood Platelets; Cardiovascular Diseases; Humans; Patents as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor	2014
Ticagrelor: a review of its use in adults with acute coronary syndromes. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015, Volume: 15, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Aging; Combined Modality Therapy; Coronary Artery Bypass; Evidence-Based Medicine; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Thrombosis; Ticagrelor	2015
Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules. Vascular pharmacology, 2015, Volume: 75 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Blood Platelets; Endothelial Cells; Endothelium, Vascular; Humans; Platelet Activation; Thrombosis	2015
On-treatment platelet reactivity: State of the art and perspectives. Vascular pharmacology, 2016, Volume: 77 Topics: Acute Coronary Syndrome; Adenosine; Age Factors; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Sex Factors; Stents; Thrombosis; Ticagrelor; Ticlopidine	2016
Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events. Expert review of cardiovascular therapy, 2016, Volume: 14, Issue:12 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Ticlopidine	2016
Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease. Current cardiology reports, 2017, Volume: 19, Issue:1 Topics: Adenosine; Blood Platelets; Coronary Artery Disease; Hemorrhage; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Thrombosis; Ticagrelor; Treatment Outcome	2017
NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors (Oxford, England), 2007, Volume: 31, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Atherosclerosis; Blood Coagulation; Blood Platelets; Cell Communication; Demyelinating Diseases; Epilepsy; Humans; Metabolism, Inborn Errors; Myocardial Infarction; Neoplasms; Platelet Activation; Platelet Aggregation; Seizures; Signal Transduction; Tamoxifen; Thrombosis	2007
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist. Expert review of cardiovascular therapy, 2010, Volume: 8, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Animals; Clinical Trials as Topic; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor	2010
Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor. Vascular health and risk management, 2010, Jun-01, Volume: 6 Topics: Adenosine; Animals; Blood Platelets; Drugs, Investigational; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Treatment Outcome	2010
Ticagrelor for the treatment of arterial thrombosis. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:13 Topics: Adenosine; Arteries; Clinical Trials as Topic; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Treatment Outcome	2010
Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors. Thrombosis and haemostasis, 2011, Volume: 105 Suppl 1 Topics: Adenosine; Adenosine Monophosphate; Animals; Clinical Trials, Phase III as Topic; Clopidogrel; Humans; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Protein Binding; Purinergic P2Y Receptor Antagonists; Quinazolinones; Sulfonamides; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2011
Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Pharmacotherapy, 2012, Volume: 32, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Animals; Clinical Trials as Topic; Coronary Artery Disease; Hemorrhage; Humans; Imines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Thiophenes; Thrombosis; Ticagrelor	2012
A2 adenosine receptors and vascular pathologies. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Animals; Atherosclerosis; Blood Vessels; Humans; Inflammation; Receptors, Adenosine A2; Signal Transduction; Thrombosis; Vascular Diseases	2012
[Platelet function: new drugs, new assays : possible impacts on operative medicine?]. Der Anaesthesist, 2012, Volume: 61, Issue:6 Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Prasugrel Hydrochloride; Predictive Value of Tests; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2012
A brief review of the past and future of platelet P2Y12 antagonist. Coronary artery disease, 2012, Volume: 23, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clopidogrel; Coronary Artery Disease; Humans; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Stents; Sulfonamides; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2012
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:3 Topics: Adenosine; Clopidogrel; Hemorrhage; Humans; Ischemia; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; PubMed; Randomized Controlled Trials as Topic; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2013
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:2 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Administration, Oral; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Rabbits; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor	2005
ADP receptor antagonism: what's in the pipeline? American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:6 Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Disease; Humans; Membrane Proteins; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2007
Prothrombin G20210A polymorphism and thrombophilia. Mayo Clinic proceedings, 2000, Volume: 75, Issue:6 Topics: Adenosine; Africa; Asia; Asian People; Black People; Brain Ischemia; Brazil; Coronary Disease; Europe; Factor V; Genetic Testing; Guanosine; Homozygote; Humans; Point Mutation; Polymorphism, Genetic; Prevalence; Prothrombin; Risk Factors; Thrombophilia; Thrombosis; United States; White People	2000
[Present status and prospects of platelet inhibitors]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1976, Volume: 17, Issue:6 Topics: Adenosine; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Depression, Chemical; Drug Combinations; Drug Synergism; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Serotonin; Theophylline; Thrombosis	1976
[The use of platelet aggregation inhibitor in nephrodialysis]. Archivio "E. Maragliano" di patologia e clinica, 1979, Volume: 35, Issue:2 Topics: Adenosine; Blood Coagulation Disorders; Epoprostenol; Heparin; Humans; Platelet Aggregation; Prostaglandins; Prostaglandins E, Synthetic; Renal Dialysis; Thrombosis	1979

Trials

15 trial(s) available for adenosine and Thrombosis

Article	Year
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascular pharmacology, 2023, Volume: 148 Topics: Adenosine; Clopidogrel; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2023
Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease. Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:3 Topics: Adenosine; Aged; Aspirin; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Time Factors	2018
Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany. Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Adult; Atherosclerosis; Clopidogrel; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Drugs, Generic; Follow-Up Studies; Germany; Humans; Markov Chains; Models, Economic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Quality-Adjusted Life Years; Thrombosis; Ticagrelor; Ticlopidine; Time Factors	2013
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke, 2013, Volume: 44, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:11 Topics: Adenosine; Administration, Oral; Adult; Anticoagulants; Antithrombin III; Aspirin; Austria; Benzimidazoles; beta-Alanine; beta-Thromboglobulin; Biomarkers; Blood Coagulation; Blood Platelets; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Healthy Volunteers; Humans; International Normalized Ratio; Male; Morpholines; Peptide Fragments; Peptide Hydrolases; Phenprocoumon; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Ticagrelor; Young Adult	2014
Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:6 Topics: Adenosine; Adult; Aspirin; Clopidogrel; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Renal Dialysis; Single-Blind Method; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2015
Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:6 Topics: Adenosine; Adult; Aged; Asian People; Aspirin; Cardiac Catheterization; Double-Blind Method; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Republic of Korea; Sample Size; Thrombophilia; Thrombosis; Ticagrelor	2015
Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:12 Topics: Adenosine; Anti-Inflammatory Agents; Biomarkers; Blood Platelets; Chemotaxis, Leukocyte; Clopidogrel; Cytokines; Endotoxins; England; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; Inflammation Mediators; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult	2015
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American heart journal, 2016, Volume: 177 Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine	2016
Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction. Journal of cardiovascular medicine (Hagerstown, Md.), 2016, Volume: 17, Issue:9 Topics: Abciximab; Adenosine; Administration, Oral; Aged; Aged, 80 and over; Antibodies, Monoclonal; Clopidogrel; Coronary Angiography; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Reperfusion; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Stents; Thrombectomy; Thrombosis; Ticagrelor; Ticlopidine; Tomography, Optical Coherence	2016
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial. American heart journal, 2016, Volume: 178 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Cause of Death; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Graft Occlusion, Vascular; Hemorrhage; Humans; Mortality; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Time Factors	2016
Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome. The Journal of international medical research, 2017, Volume: 45, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Aged; Alleles; Asian People; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Gene Expression; Gene Frequency; Genotype; Genotyping Techniques; Humans; Male; Middle Aged; Mutation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Ticlopidine	2017
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. American heart journal, 2012, Volume: 164, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Smoking; Stents; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2012
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation, 2013, Feb-12, Volume: 127, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Severity of Illness Index; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Prevention of early postoperative graft thrombosis in pancreatic transplantation. Transplantation proceedings, 1993, Volume: 25, Issue:4 Topics: Adenosine; Allopurinol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glutathione; Humans; Hypertonic Solutions; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Organ Preservation; Organ Preservation Solutions; Pancreas; Pancreas Transplantation; Postoperative Complications; Raffinose; Retrospective Studies; Thrombosis	1993

Other Studies

74 other study(ies) available for adenosine and Thrombosis

Article	Year
Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Adenosine Diphosphate; Clopidogrel; Complement C1q; Coronary Artery Disease; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Ticlopidine	2022
High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women. Biomolecules, 2022, Oct-17, Volume: 12, Issue:10 Topics: Adenosine; Adenosine Diphosphate; Aspirin; Cyclooxygenase 1; Diphosphates; Dual Anti-Platelet Therapy; Epoprostenol; Estrogens; Exercise; Female; Humans; Nitric Oxide; Peptides; Platelet Aggregation Inhibitors; Postmenopause; Receptors, Epoprostenol; Receptors, Thromboxane; Thrombin; Thrombosis; Thromboxanes	2022
The effect of ticagrelor on microarterial thrombosis in an experimental model. Journal of plastic surgery and hand surgery, 2021, Volume: 55, Issue:5 Topics: Adenosine; Animals; Clopidogrel; Models, Theoretical; Platelet Aggregation Inhibitors; Rats; Thrombosis; Ticagrelor; Ticlopidine	2021
DNAse-dependent, NET-independent pathway of thrombus formation in vivo. Proceedings of the National Academy of Sciences of the United States of America, 2021, 07-13, Volume: 118, Issue:28 Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Deoxyribonuclease I; Extracellular Traps; Fibrin; Humans; Hydrolysis; Lasers; Leukocyte Elastase; Mice, Inbred C57BL; Models, Biological; Neutrophil Activation; Neutrophils; Platelet Activation; Protein-Arginine Deiminase Type 4; Thrombosis	2021
Administration of Ticagrelor and Double-Dose Clopidogrel Based on Platelet Reactivity Determined by VerifyNow-P2Y12 for Chinese Subjects After Elective PCI. International heart journal, 2017, Apr-06, Volume: 58, Issue:2 Topics: Adenosine; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Ticlopidine	2017
Repetitive stent thrombosis in a patient with suspected allergy to aspirin and multiple switch between clopidogrel, prasugrel, and ticagrelor. Kardiologia polska, 2017, Volume: 75, Issue:6 Topics: Adenosine; Aspirin; Clopidogrel; Coronary Vessels; Drug Hypersensitivity; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Recurrence; Stents; Thrombosis; Ticagrelor; Ticlopidine	2017
High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition. Thrombosis research, 2013, Volume: 131, Issue:4 Topics: Adenosine; Animals; Arachidonic Acid; Aspirin; Clopidogrel; Dogs; Dose-Response Relationship, Drug; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Ticlopidine; Vascular Resistance	2013
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition. Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:6 Topics: Adenosine; Animals; Anticoagulants; Chlorides; Contrast Media; Enoxaparin; Ferric Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbubbles; Microscopy; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Sulfur Hexafluoride; Thrombosis; Ticagrelor; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis	2013
Ticagrelor immediately prior to stenting is associated with smaller residual thrombus in patients with acute coronary syndrome. International journal of cardiology, 2013, Oct-03, Volume: 168, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Care; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stents; Thrombosis; Ticagrelor	2013
Challenging ticagrelor's claimed reduction in the rate of definite stent thrombosis versus clopidogrel: insights from the FDA reports. International journal of cardiology, 2013, Sep-30, Volume: 168, Issue:2 Topics: Adenosine; Clopidogrel; Drug-Eluting Stents; Humans; Randomized Controlled Trials as Topic; Thrombosis; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration	2013
HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Annals of transplantation, 2013, Feb-20, Volume: 18 Topics: Adenosine; Adult; Allopurinol; Anastomosis, Surgical; Anastomotic Leak; Biliary Tract; Constriction, Pathologic; Female; Glucose; Glutathione; Hepatic Artery; Humans; Insulin; Liver Transplantation; Male; Mannitol; Middle Aged; Organ Preservation Solutions; Postoperative Complications; Potassium Chloride; Procaine; Raffinose; Reoperation; Retrospective Studies; Thrombosis; Tissue Donors	2013
Letter by Serebruany and DiNicolantonio regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke, 2013, Volume: 44, Issue:8 Topics: Acute Coronary Syndrome; Adenosine; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis	2013
Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke, 2013, Volume: 44, Issue:8 Topics: Acute Coronary Syndrome; Adenosine; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis	2013
First report of a subacute stent thrombosis in a prasugrel resistant patient successfully managed with ticagrelor. Platelets, 2014, Volume: 25, Issue:8 Topics: Adenosine; Drug Resistance; Humans; Male; Middle Aged; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thrombosis; Ticagrelor	2014
Signaling via P2Y12 may be critical for early stabilization of platelet aggregates. Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:6 Topics: Adenosine; Animals; Humans; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thrombosis; Ticagrelor; Time Factors	2014
Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome. International journal of cardiology, 2014, Oct-20, Volume: 176, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Piperazines; Postoperative Care; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Recurrence; Retrospective Studies; Thiophenes; Thrombosis; Ticagrelor	2014
First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea. International journal of cardiology, 2014, Oct-20, Volume: 176, Issue:3 Topics: Adenosine; Aged; Clopidogrel; Drug Substitution; Dyspnea; Humans; Male; Purinergic P2Y Receptor Antagonists; Stents; Thrombosis; Ticagrelor; Ticlopidine	2014
Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling. PloS one, 2014, Volume: 9, Issue:11 Topics: Adenosine; Animals; Blood Coagulation; Blood Platelets; Collagen; Humans; Inosine; Male; Mice; Models, Biological; Platelet Adhesiveness; Thrombosis	2014
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome. Thrombosis research, 2015, Volume: 135, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin	2015
Balancing the risks and benefits of dual platelet inhibition. The New England journal of medicine, 2015, May-07, Volume: 372, Issue:19 Topics: Adenosine; Aspirin; Drug-Eluting Stents; Female; Humans; Male; Piperazines; Platelet Aggregation Inhibitors; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2015
[ATLANTIC trial and feasibility of early administration of ticagrelor in myocardial infarction]. Kardiologiia, 2014, Volume: 54, Issue:11 Topics: Adenosine; Coronary Circulation; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticagrelor; Time-to-Treatment; Treatment Outcome	2014
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. Vascular pharmacology, 2016, Volume: 77 Topics: Acute Coronary Syndrome; Adenosine; Age Factors; Aged; Blood Platelets; Drug Therapy, Combination; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Predictive Value of Tests; Stents; Thrombosis; Ticagrelor	2016
Platelet inhibition with ticagrelor for left ventricular assist device thrombosis. Circulation. Heart failure, 2015, Volume: 8, Issue:3 Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Thrombosis; Ticagrelor; Treatment Outcome; Ventricular Function, Left	2015
Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention. Journal of managed care & specialty pharmacy, 2015, Volume: 21, Issue:7 Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Genetic Testing; Genotype; Humans; Managed Care Programs; Models, Economic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thrombosis; Ticagrelor; Ticlopidine	2015
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1 Topics: Adenosine; Adenosine Diphosphate; Age Factors; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Clopidogrel; Cohort Studies; Female; Humans; Male; Middle Aged; Odds Ratio; Patient Discharge; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prevalence; Thrombosis; Ticagrelor; Ticlopidine; Time Factors	2016
Pneumonitis and pulmonary haemorrhage after acute myocardial infarction. Clinical medicine (London, England), 2015, Volume: 15, Issue:6 Topics: Adenosine; Angioplasty; Hemoptysis; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Pneumonia; Purinergic P2Y Receptor Antagonists; Radiography, Thoracic; Thrombosis; Ticagrelor	2015
Diffuse alveolar hemorrhage associated with low molecular weight heparin and dual anti-platelet therapy after percutaneous coronary intervention. The clinical respiratory journal, 2017, Volume: 11, Issue:6 Topics: Adenosine; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Fatal Outcome; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pulmonary Alveoli; Purinergic P2Y Receptor Antagonists; Risk Factors; Stents; Thrombosis; Ticagrelor	2017
Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2). PloS one, 2016, Volume: 11, Issue:6 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Clopidogrel; Early Diagnosis; Female; Humans; Israel; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Stents; Stroke; Survival Analysis; Thrombosis; Ticagrelor; Ticlopidine	2016
Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution. International journal of cardiology, 2016, Oct-15, Volume: 221 Topics: Adenosine; Aged; Aspirin; Blood Coagulation; Cardiomyopathies; Clopidogrel; Drug Substitution; Drug Therapy, Combination; Fibrinolytic Agents; Heart-Assist Devices; Humans; Male; Medication Therapy Management; Postoperative Complications; Risk Adjustment; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2016
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Arterial Occlusive Diseases; Blood Coagulation; Bone Marrow Transplantation; Chlorides; Disease Models, Animal; Endothelial Cells; Ferric Compounds; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hydrolysis; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monocytes; Phenotype; Platelet Activation; Thrombosis; Time Factors; Transfection	2016
Biocatalytic approaches to a key building block for the anti-thrombotic agent ticagrelor. Organic & biomolecular chemistry, 2016, Sep-14, Volume: 14, Issue:34 Topics: Adenosine; Amines; Biocatalysis; Chemistry Techniques, Synthetic; Hydrolysis; Thrombosis; Ticagrelor	2016
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology. Journal of cardiovascular medicine (Hagerstown, Md.), 2017, Volume: 18, Issue:1 Topics: Adenosine; Aspirin; Cardiology; Drug Administration Schedule; Drug-Eluting Stents; Hemorrhage; Humans; Italy; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Societies, Medical; Thrombosis; Ticagrelor	2017
In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention. Platelets, 2017, Volume: 28, Issue:3 Topics: Adenosine; Blood Platelets; Clopidogrel; Drug Administration Schedule; Drug Dosage Calculations; Drug Substitution; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Stents; Thrombosis; Ticagrelor; Ticlopidine	2017
Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression. Cardiovascular research, 2017, Volume: 113, Issue:1 Topics: Adenosine; Animals; Blood Coagulation; Blood Platelets; Carotid Artery Injuries; Cells, Cultured; Clopidogrel; Disease Models, Animal; Down-Regulation; Endothelial Cells; Equilibrative Nucleoside Transporter 1; Fibrinolytic Agents; Humans; Male; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Proteasome Endopeptidase Complex; Proteolysis; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thromboplastin; Thrombosis; Ticagrelor; Ticlopidine; Time Factors; Tumor Necrosis Factor-alpha	2017
Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:4 Topics: Adenosine; Adenosine Triphosphatases; Animals; Apyrase; Blood Platelets; Blood Vessels; Carotid Arteries; Cell Movement; Cell Proliferation; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Hemostasis; Humans; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Prothrombin Time; Recombinant Proteins; Solubility; Thrombosis; Tunica Intima	2017
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. Journal of vascular surgery, 2009, Volume: 49, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Animals; Aorta; Aortic Aneurysm, Abdominal; Blood Platelets; Disease Models, Animal; Disease Progression; Elastic Tissue; Guinea Pigs; Inflammation; Male; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred Lew; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Time Factors; Transplantation, Heterologous	2009
Ticagrelor, a platelet aggregation inhibitor for the potential prevention and treatment of arterial thrombosis and acute coronary syndromes. IDrugs : the investigational drugs journal, 2009, Volume: 12, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Molecular Structure; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Thrombosis; Ticagrelor; Treatment Outcome	2009
Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis. Thrombosis research, 2009, Volume: 124, Issue:5 Topics: Adenosine; Animals; CHO Cells; Clopidogrel; Cricetinae; Cricetulus; Disease Models, Animal; Dogs; Hemostasis; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine; Transfection	2009
Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12 Topics: Adenosine; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Tunica Intima	2010
Ticagrelor to prevent restenosis: new drug for an old hypothesis? Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:12 Topics: Adenosine; Animals; Blood Coagulation; Blood Platelets; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Proliferation; Coronary Restenosis; Fibrinolytic Agents; Humans; Mice; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Tunica Intima	2010
Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor. Circulation, 2011, Feb-01, Volume: 123, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Advisory Committees; Aspirin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clopidogrel; Drug Approval; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Thrombosis; Ticagrelor; Ticlopidine; United States	2011
Fresh from the pipeline. Ticagrelor. Nature reviews. Drug discovery, 2011, Volume: 10, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Adult; Atherosclerosis; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor	2011
The use of ticagrelor in a patient at increased risk of stent thrombosis resistant to multiple thienopyridines. Cardiology, 2011, Volume: 119, Issue:2 Topics: Adenosine; Aged, 80 and over; Cardiac Catheterization; Clopidogrel; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Thienopyridines; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2011
BF061, a novel antiplatelet and antithrombotic agent targeting P2Y₁₂ receptor and phosphodiesterase. Thrombosis and haemostasis, 2011, Volume: 106, Issue:6 Topics: Adenosine; Adenosine Monophosphate; Animals; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Fibrinolytic Agents; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis	2011
Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor. Thrombosis and haemostasis, 2011, Volume: 106, Issue:6 Topics: Adenosine; Adenosine Diphosphate; Animals; Blood Platelets; Clopidogrel; Cytoprotection; Platelet Activation; Protein Binding; Purinergic P2Y Receptor Antagonists; Rats; Rats, Inbred WKY; Thrombosis; Ticagrelor; Ticlopidine	2011
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings. The British journal of radiology, 2012, Volume: 85, Issue:1018 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Bundle-Branch Block; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Chronic Disease; Contrast Media; Coronary Stenosis; Cysts; Dobutamine; Exercise Test; Gadolinium DTPA; Heart Neoplasms; Heart Valve Diseases; Humans; Incidental Findings; Lipoma; Liver Diseases; Magnetic Resonance Angiography; Middle Aged; Multiple Pulmonary Nodules; Referral and Consultation; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thrombosis; Vasodilator Agents; Ventricular Dysfunction, Left	2012
Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor. Platelets, 2012, Volume: 23, Issue:5 Topics: Adenosine; Aged; Cardiopulmonary Resuscitation; Clopidogrel; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Shock, Cardiogenic; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine	2012
Antiplatelet therapy - ticagrelor. Hamostaseologie, 2012, Volume: 32, Issue:3 Topics: Adenosine; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Treatment Outcome	2012
BF066, a novel dual target antiplatelet agent without significant bleeding. PloS one, 2012, Volume: 7, Issue:7 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arterioles; Chlorides; Collagen; Ferric Compounds; Fibrinogen; Hemorrhage; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Thrombin; Thrombosis	2012
What's new in the UA/NSTEMI guidelines? Nursing, 2012, Volume: 42, Issue:12 Topics: Adenosine; Angina, Unstable; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Thrombosis; Ticagrelor	2012
A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats. British journal of pharmacology, 2013, Volume: 169, Issue:1 Topics: Adenosine; Animals; Blood Coagulation Tests; Dose-Response Relationship, Drug; Hemorrhage; Hemostasis; Male; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prodrugs; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Risk; Thiophenes; Thrombosis; Ticagrelor	2013
INHIBITION BY ADENOSINE AND BY 2-CHLOROADENOSINE OF THE FORMATION AND EMBOLIZATION OF PLATELET THROMBI. Nature, 1964, May-23, Volume: 202 Topics: 2-Chloroadenosine; Adenosine; Blood Platelets; Nucleosides; Pharmacology; Rabbits; Research; Thrombosis; Wounds and Injuries	1964
EFFECT OF ADENOSINE ON PLATELET ADHESIVENESS IN FASTING AND LIPAEMIC BLOODS. Lancet (London, England), 1965, Jul-31, Volume: 2, Issue:7405 Topics: Adenosine; Blood Platelets; Dietary Fats; Fasting; Humans; Lipids; Nucleosides; Pharmacology; Platelet Adhesiveness; Thrombosis	1965
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. The Journal of clinical investigation, 2004, Volume: 113, Issue:10 Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphatases; Animals; Antigens, CD; Apyrase; Blood Platelets; Bone Marrow Transplantation; Gene Expression; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Phenotype; Thrombosis; Transplantation Immunology	2004
Treatment of saphenous vein graft thrombosis with distal protection, thrombectomy, and adenosine prior to reperfusion: a complete approach to preserving microvascular integrity. The Journal of invasive cardiology, 2004, Volume: 16, Issue:6 Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Female; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Saphenous Vein; Stents; Thrombectomy; Thrombosis; Vasodilator Agents	2004
Dual lumen catheters: more than just aspiration. The Journal of invasive cardiology, 2006, Volume: 18, Issue:7 Topics: Adenosine; Biopsy, Fine-Needle; Cardiac Catheterization; Coronary Vessels; Embolism; Humans; Nitroprusside; Stents; Thrombosis; Vasodilation	2006
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis. Bioorganic & medicinal chemistry letters, 2007, Nov-01, Volume: 17, Issue:21 Topics: Adenosine; Adenosine Triphosphate; Administration, Oral; Animals; Humans; Membrane Proteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor	2007
Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury. European journal of pharmacology, 1995, Aug-04, Volume: 281, Issue:2 Topics: Adenosine; Alkynes; Animals; Antihypertensive Agents; Femoral Artery; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Thrombosis; Time Factors	1995
Pancreas transplant functional salvage after segmental vascular thrombosis. Transplantation proceedings, 1993, Volume: 25, Issue:2 Topics: Adenosine; Adult; Allopurinol; Amylases; Blood Glucose; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Duodenum; Glutathione; Histocompatibility Testing; Humans; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Pancreas Transplantation; Raffinose; Solutions; Spleen; Thrombosis; Tomography, X-Ray Computed; Transplantation, Homologous	1993
Incidence of vascular complications in kidney transplantation: is there any interference with the nature of the perfusion solution? Clinical transplantation, 1994, Volume: 8, Issue:5 Topics: Adenosine; Adult; Allopurinol; Glutathione; Humans; Hypertonic Solutions; Insulin; Kidney Transplantation; Organ Preservation; Organ Preservation Solutions; Raffinose; Renal Artery Obstruction; Renal Veins; Thrombosis	1994
Back-table renal allograft angioscopy and thrombolysis. Transplant international : official journal of the European Society for Organ Transplantation, 1994, Volume: 7, Issue:1 Topics: Adenosine; Allopurinol; Angioscopy; Glutathione; Humans; Insulin; Kidney Transplantation; Male; Middle Aged; Organ Preservation Solutions; Raffinose; Renal Artery Obstruction; Streptokinase; Thrombolytic Therapy; Thrombosis; Transplantation, Homologous	1994
Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation, 1993, Volume: 56, Issue:6 Topics: Adenosine; Adult; Aged; Allopurinol; Child, Preschool; Cold Temperature; Glutathione; Hepatic Artery; Humans; Insulin; Ischemia; Liver; Liver Transplantation; Middle Aged; Organ Preservation; Organ Preservation Solutions; Raffinose; Thrombosis; Time Factors; Ultrasonography	1993
Donor criteria and technical aspects of procurement in combined pancreas and kidney transplantation from non-heart-beating cadavers. Transplantation proceedings, 1995, Volume: 27, Issue:6 Topics: Adenosine; Adolescent; Adult; Allopurinol; Cadaver; Female; Glutathione; Graft Rejection; Humans; Insulin; Ischemia; Isotonic Solutions; Kidney; Kidney Transplantation; Male; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pancreas; Pancreas Transplantation; Perfusion; Raffinose; Ringer's Solution; Therapeutic Irrigation; Thrombosis; Tissue and Organ Procurement; Tissue Donors	1995
Preserved vascular homograft for revascularization of pediatric liver transplant: a clinical, histological, and bacteriological study. Transplantation, 1999, Sep-15, Volume: 68, Issue:5 Topics: Adenosine; Adolescent; Allopurinol; Bacteria; Child; Child, Preschool; Cryopreservation; Endothelium, Vascular; Glutathione; Humans; Iliac Artery; Iliac Vein; Infant; Insulin; Isotonic Solutions; Liver; Liver Transplantation; Organ Preservation Solutions; Postoperative Complications; Raffinose; Retrospective Studies; Thrombosis; Tissue Donors; Vascular Patency	1999
Experimental rupture of atherosclerotic lesions increases distal vascular resistance: a limiting factor to the success of infarct angioplasty. Arteriosclerosis, thrombosis, and vascular biology, 2002, Volume: 22, Issue:1 Topics: Adenosine; Animals; Arteriosclerosis; Capillary Permeability; Hindlimb; Iliac Artery; Microcirculation; Models, Animal; Muscle, Skeletal; Nitroglycerin; Nitroprusside; Rabbits; Regional Blood Flow; Rupture, Spontaneous; Thrombosis; Vascular Resistance; Vasodilation	2002
A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate-induced platelet aggregation. Lancet (London, England), 1977, Aug-13, Volume: 2, Issue:8033 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Aorta; Apyrase; Cell Extracts; Cell Membrane; Phosphoric Monoester Hydrolases; Platelet Aggregation; Rabbits; Thrombosis	1977
Regional administration of drugs to control thrombosis in artificial organs. Transactions - American Society for Artificial Internal Organs, 1976, Volume: 22 Topics: Adenosine; Animals; Artificial Organs; Blood Cell Count; Blood Coagulation; Blood Platelets; Dipyridamole; Drug Synergism; Kidneys, Artificial; Sheep; Thrombosis	1976
Diffuse biliary tract injury after orthotopic liver transplantation. American journal of surgery, 1992, Volume: 164, Issue:5 Topics: Adenosine; Adolescent; Adult; Aged; Alanine Transaminase; Allopurinol; Aspartate Aminotransferases; Bile Duct Diseases; Biliary Tract Diseases; Child; Child, Preschool; Cholangitis; Follow-Up Studies; Glutathione; Graft Survival; Hepatic Artery; Humans; Hypertonic Solutions; Infant; Infant, Newborn; Insulin; Jaundice; Liver; Liver Transplantation; Middle Aged; Organ Preservation; Organ Preservation Solutions; Raffinose; Reoperation; Retrospective Studies; Solutions; Thrombosis	1992
Improved arterial allograft preservation with the University of Wisconsin solution. Transplantation proceedings, 1991, Volume: 23, Issue:1 Pt 1 Topics: Adenosine; Allopurinol; Animals; Dogs; Female; Glutathione; Iliac Artery; Insulin; Microscopy, Electron; Muscle, Smooth, Vascular; Organ Preservation; Organ Preservation Solutions; Raffinose; Solutions; Thrombosis; Transplantation, Homologous	1991
Current status of organ preservation with University of Wisconsin solution. Archives of pathology & laboratory medicine, 1991, Volume: 115, Issue:3 Topics: Adenosine; Adolescent; Allopurinol; Child; Child, Preschool; Glutathione; Graft Survival; Hepatic Artery; Humans; Infant; Insulin; Kidney Transplantation; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Pancreas; Pancreas Transplantation; Postoperative Complications; Raffinose; Reoperation; Solutions; Thrombosis; Time Factors	1991
Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis, 1987, Volume: 66, Issue:3 Topics: 2-Chloroadenosine; Adenosine; Adult; Aged; Aspirin; Epoprostenol; Erythrocytes; Humans; Iloprost; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Count; Sulfonamides; Thrombosis	1987
Leucocytes and thrombosis. 3. Effect on white cell behaviour of substances which induce or inhibit platelet aggregation. Thrombosis et diathesis haemorrhagica, 1973, Sep-15, Volume: 30, Issue:1 Topics: Adenosine; Aspirin; Catecholamines; Collagen; Dipyridamole; Epinephrine; Isoproterenol; Leukocytes; Norepinephrine; Serotonin; Tendons; Thrombosis	1973
Inhibition of platelet-induced thrombus formation. Schweizerische medizinische Wochenschrift, 1974, Jan-26, Volume: 104, Issue:4 Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrine; Glomerulonephritis; Heart Valve Prosthesis; Humans; Hypertension, Malignant; Ischemia; Myocardial Infarction; Platelet Adhesiveness; Postoperative Complications; Prostaglandins; Pyrimidines; Thromboembolism; Thrombophlebitis; Thrombosis; Xanthines	1974
Involvement of platelets and microthrombi in experimental decompression sickness: similarities with disseminated intravascular coagulation. Aerospace medicine, 1971, Volume: 42, Issue:5 Topics: Adenosine; Adenosine Diphosphate; Air; Animals; Blood Cell Count; Blood Platelets; Cerebral Cortex; Decompression Sickness; Disseminated Intravascular Coagulation; Erythrocyte Aggregation; Injections, Intra-Arterial; Injections, Intravenous; Lung; Male; Platelet Adhesiveness; Rabbits; Rats; Serotonin; Thrombosis	1971